Google
ARDX — ARDELYX INC (Healthcare >> Biotechnology)
ARDX FAQ
What is ARDX's ROE?
ARDELYX INC reports a Return on Equity (ROE) of -39.07%.
What is ARDX's dividend yield?
ARDELYX INC offers a dividend yield of 0.00%.
What is ARDX's Deepscope Quality Score?
Deepscope rates ARDX's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ARDX?
Deepscope's AI Timing Score for ARDX is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ARDX belong to?
ARDELYX INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 5.42
Price
-0.10
(-1.81%)
Day Change
|
|
|---|
ARDX, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
39% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 93 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 5.42 |
| PBV / Sector |
9.17 / 4.48
|
| Earning Per Share | -0.23 |
| PE / Sector |
N/A / 16.68
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
20.55 M
GREAT
|
| Average 1W Daily Value |
17.47 M
GREAT
|
| Timing Factors |
|
14% |
| Financial Health |
|
43% |
| Ability to Make Profit |
|
52% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-04 09:23:35 |
| Symbol | ARDX |
| Name | ARDELYX INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 247.03 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,363.60 / 8,483.11 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 400 Fifth Avenue, Waltham, MA, United States, 02451
Phone: 510 745 1700
Website: https://www.ardelyx.com
Employees: 489
Sector: Healthcare >> Biotechnology
Description: Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
